Selected research
Industry Research
Oral Veterinary Pain Management Drugs Industry Research Report 2026
Market perspective
The global Oral Veterinary Pain Management Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Oral Veterinary Pain Management Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Oral Veterinary Pain Management Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Oral Veterinary Pain Management Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Oral Veterinary Pain Management Drugs include Zoetis, Merck & Co, Medtronic, Lilly, Bayer Pharma AG, Baxter, Norbrook Laboratories, Halyard and Forest Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Oral Veterinary Pain Management Drugs market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Oral Veterinary Pain Management Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Veterinary Pain Management Drugs Market by Company
Zoetis
Merck & Co
Medtronic
Lilly
Bayer Pharma AG
Baxter
Norbrook Laboratories
Halyard
Forest Laboratories
Endo International
Elanco
Ceva Sante Animale
Bostonscientific
Boehringer Ingelheim
Oral Veterinary Pain Management Drugs Segment by Type
Sedatives
Local Anesthetics
Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
Opioids
α2-Adrenergic Agonists
Other
Oral Veterinary Pain Management Drugs Segment by Application
Veterinary Clinics
Veterinary Hospitals
For Retail
Others
Oral Veterinary Pain Management Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Veterinary Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Veterinary Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Veterinary Pain Management Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oral Veterinary Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sedatives
- Local Anesthetics
- Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
- Opioids
- α2-Adrenergic Agonists
- Other
Applications
- Veterinary Clinics
- Veterinary Hospitals
- For Retail
- Others
Companies covered
- Zoetis
- Merck & Co
- Medtronic
- Lilly
- Bayer Pharma AG
- Baxter
- Norbrook Laboratories
- Halyard
- Forest Laboratories
- Endo International
- Elanco
- Ceva Sante Animale
- Bostonscientific
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oral Veterinary Pain Management Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Sedatives
- 2.2.3 Local Anesthetics
- 2.2.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
- 2.2.5 Opioids
- 2.2.6 α2-Adrenergic Agonists
- 2.2.7 Other
- 2.3 Oral Veterinary Pain Management Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Veterinary Clinics
- 2.3.3 Veterinary Hospitals
- 2.3.4 For Retail
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Oral Veterinary Pain Management Drugs Breakdown Data by Type
- 3.1 Global Oral Veterinary Pain Management Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Oral Veterinary Pain Management Drugs Forecasted Market Size by Type (2027-2032)
4 Oral Veterinary Pain Management Drugs Breakdown Data by Application
- 4.1 Global Oral Veterinary Pain Management Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Oral Veterinary Pain Management Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Oral Veterinary Pain Management Drugs Market Perspective (2021-2032)
- 5.2 Global Oral Veterinary Pain Management Drugs Growth Trends by Region
- 5.2.1 Global Oral Veterinary Pain Management Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Oral Veterinary Pain Management Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Oral Veterinary Pain Management Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Oral Veterinary Pain Management Drugs Market Dynamics
- 5.3.1 Oral Veterinary Pain Management Drugs Industry Trends
- 5.3.2 Oral Veterinary Pain Management Drugs Market Drivers
- 5.3.3 Oral Veterinary Pain Management Drugs Market Challenges
- 5.3.4 Oral Veterinary Pain Management Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Oral Veterinary Pain Management Drugs Players by Revenue
- 6.1.1 Global Top Oral Veterinary Pain Management Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Oral Veterinary Pain Management Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Oral Veterinary Pain Management Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Oral Veterinary Pain Management Drugs Head Office and Area Served
- 6.4 Global Oral Veterinary Pain Management Drugs Players, Product Type & Application
- 6.5 Global Oral Veterinary Pain Management Drugs Manufacturers Established Date
- 6.6 Global Oral Veterinary Pain Management Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Oral Veterinary Pain Management Drugs Market Size (2021-2032)
- 7.2 North America Oral Veterinary Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Oral Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 7.4 North America Oral Veterinary Pain Management Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Oral Veterinary Pain Management Drugs Market Size (2021-2032)
- 8.2 Europe Oral Veterinary Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Oral Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 8.4 Europe Oral Veterinary Pain Management Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Oral Veterinary Pain Management Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Oral Veterinary Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Oral Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Oral Veterinary Pain Management Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Oral Veterinary Pain Management Drugs Market Size (2021-2032)
- 10.2 South America Oral Veterinary Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Oral Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 10.4 South America Oral Veterinary Pain Management Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Oral Veterinary Pain Management Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Oral Veterinary Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Oral Veterinary Pain Management Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Oral Veterinary Pain Management Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zoetis
- 12.1.1 Zoetis Company Information
- 12.1.2 Zoetis Business Overview
- 12.1.3 Zoetis Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.1.4 Zoetis Oral Veterinary Pain Management Drugs Product Portfolio
- 12.1.5 Zoetis Recent Developments
- 12.2 Merck & Co
- 12.2.1 Merck & Co Company Information
- 12.2.2 Merck & Co Business Overview
- 12.2.3 Merck & Co Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.2.4 Merck & Co Oral Veterinary Pain Management Drugs Product Portfolio
- 12.2.5 Merck & Co Recent Developments
- 12.3 Medtronic
- 12.3.1 Medtronic Company Information
- 12.3.2 Medtronic Business Overview
- 12.3.3 Medtronic Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.3.4 Medtronic Oral Veterinary Pain Management Drugs Product Portfolio
- 12.3.5 Medtronic Recent Developments
- 12.4 Lilly
- 12.4.1 Lilly Company Information
- 12.4.2 Lilly Business Overview
- 12.4.3 Lilly Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.4.4 Lilly Oral Veterinary Pain Management Drugs Product Portfolio
- 12.4.5 Lilly Recent Developments
- 12.5 Bayer Pharma AG
- 12.5.1 Bayer Pharma AG Company Information
- 12.5.2 Bayer Pharma AG Business Overview
- 12.5.3 Bayer Pharma AG Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.5.4 Bayer Pharma AG Oral Veterinary Pain Management Drugs Product Portfolio
- 12.5.5 Bayer Pharma AG Recent Developments
- 12.6 Baxter
- 12.6.1 Baxter Company Information
- 12.6.2 Baxter Business Overview
- 12.6.3 Baxter Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.6.4 Baxter Oral Veterinary Pain Management Drugs Product Portfolio
- 12.6.5 Baxter Recent Developments
- 12.7 Norbrook Laboratories
- 12.7.1 Norbrook Laboratories Company Information
- 12.7.2 Norbrook Laboratories Business Overview
- 12.7.3 Norbrook Laboratories Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.7.4 Norbrook Laboratories Oral Veterinary Pain Management Drugs Product Portfolio
- 12.7.5 Norbrook Laboratories Recent Developments
- 12.8 Halyard
- 12.8.1 Halyard Company Information
- 12.8.2 Halyard Business Overview
- 12.8.3 Halyard Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.8.4 Halyard Oral Veterinary Pain Management Drugs Product Portfolio
- 12.8.5 Halyard Recent Developments
- 12.9 Forest Laboratories
- 12.9.1 Forest Laboratories Company Information
- 12.9.2 Forest Laboratories Business Overview
- 12.9.3 Forest Laboratories Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.9.4 Forest Laboratories Oral Veterinary Pain Management Drugs Product Portfolio
- 12.9.5 Forest Laboratories Recent Developments
- 12.10 Endo International
- 12.10.1 Endo International Company Information
- 12.10.2 Endo International Business Overview
- 12.10.3 Endo International Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.10.4 Endo International Oral Veterinary Pain Management Drugs Product Portfolio
- 12.10.5 Endo International Recent Developments
- 12.11 Elanco
- 12.11.1 Elanco Company Information
- 12.11.2 Elanco Business Overview
- 12.11.3 Elanco Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.11.4 Elanco Oral Veterinary Pain Management Drugs Product Portfolio
- 12.11.5 Elanco Recent Developments
- 12.12 Ceva Sante Animale
- 12.12.1 Ceva Sante Animale Company Information
- 12.12.2 Ceva Sante Animale Business Overview
- 12.12.3 Ceva Sante Animale Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.12.4 Ceva Sante Animale Oral Veterinary Pain Management Drugs Product Portfolio
- 12.12.5 Ceva Sante Animale Recent Developments
- 12.13 Bostonscientific
- 12.13.1 Bostonscientific Company Information
- 12.13.2 Bostonscientific Business Overview
- 12.13.3 Bostonscientific Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.13.4 Bostonscientific Oral Veterinary Pain Management Drugs Product Portfolio
- 12.13.5 Bostonscientific Recent Developments
- 12.14 Boehringer Ingelheim
- 12.14.1 Boehringer Ingelheim Company Information
- 12.14.2 Boehringer Ingelheim Business Overview
- 12.14.3 Boehringer Ingelheim Revenue in Oral Veterinary Pain Management Drugs Business (2021-2026)
- 12.14.4 Boehringer Ingelheim Oral Veterinary Pain Management Drugs Product Portfolio
- 12.14.5 Boehringer Ingelheim Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst